期刊文献+

胰岛素抵抗和微量白蛋白尿关系的探讨 被引量:2

STUDY ON RELATIONSHIP BETWEEN URINARY ALBUMIN EXCRETION RATE AND INSULIN RESISTANCE IN POSTPRANDIAL HYPERGLYCEMIC SUBJECTS
下载PDF
导出
摘要 目的 :探讨餐后高血糖人群中微量白蛋白尿和胰岛素抵抗的关系及其影响因素。方法 :将以微量血糖筛查餐后 2 h血糖超过 6 .6 7mm ol/ L 参试者 739例 ,分为正常和微量白蛋白尿两组。结果 :微量白蛋白尿组的年龄、BMI、WHR、SBP、DBP、FBG、AU CBG、HOMA- IR指标均较高 ,两组比较 ,有显著性差异 (P <0 .0 5或 P <0 .0 1) ,而性别、HR、HOMA- IS、FINS、AUCINS和 TG均无显著性差异 (P >0 .0 5 )。在以 U AER为二分变量 ,其它各指标为协变量的非条件 L ogistic回归方程中 ,DBP、 AUCBG、 HOMA- IR变量能进入回归方程 ,而以 HOMA - IR为应变量 ,以年龄、 BMI、 WHR、 SBP、 DBP和 UAER为自变量建立多元线性回归模型 ,结果表明 U AER、 BMI和 WHR对 HOMA- IR有预报作用。结论 :1影响微量白蛋白尿的因素较多 ,其中最主要的 3个因素依次为 HOMA- IR、 DBP、 AU CBG。 2 U AER临床可以预测 IR的存在。 Objective To investigate relationship between urinary albumin excretion rate (UAER) and insulin resistance in postprandial hyperglycemic subjects Method:739 participants were elected with postprandial finger tip blood sugar ≥ 6 67 mmol/L The participants were divided into two groups: normal and microalbuminuria group Results:Age?BMI?WHR ?SBP?DBP ?FBG?AUC BG ?HOMA IR in microalbuminuria group were higher than those in normalbuminuria group significantly Logistic regression analysis was performed with UAER as dependant variable, and age?BMI?WHR?SBP?DBP?AUC BG ?HOMA IR as independent variable The results showed that DBP?AUC BG ?HOMA IR entered regression equation Linear multivariable regression was performed too,with HOMA IR as dependant variable and age?BMI?WHR?SBP?DBP?UAER as independent variables The results showed that UAER?BMI and WHR could predict the development of HOMA IR Conclusion:①There are many factors which effect UAER, the most important factors are HOMA IR?DBP?AUC BG ?②UAER can predict the existence of insulin resistance in clinic practice
出处 《广西医科大学学报》 CAS 2001年第6期813-815,共3页 Journal of Guangxi Medical University
关键词 微量白蛋白尿 胰岛素抵抗 2型糖尿病 microalbuminuria insulin resistance type 2 diabetes melletus
  • 相关文献

参考文献12

  • 1[1]Savage S, Estacio RO, Jeffers B, et al. Urinary albumin excretion as a predictor of diabetic retinopathy, neuropathy, and cardiovascular disease in NIDDM. Diabetes Care,1996,19(11):1 243.
  • 2[2]Haffner SM,Gonzalez C,MIiettinen H,et al. A prospective analysis of the HOMA model. The Mecico City diabetes study. Diabetes Care, 1996,19 : 1 138.
  • 3[3]Damsgaard EM, Froland A, Jorgensen OD, et al. Microalbuminuria as predictor of increased mortality in elderly people. BMJ,1990,300(672 0):297.
  • 4[4]Jensen JS,Borch JK,Jensen G,et al. Atherosclerotic risk factors are increased in clinically healthy subjects with microalbuminuria. Atherosclerosis , 1995,112 (2): 245.
  • 5[5]James MA, Fotherby MD,Potter JF. Screening tests for microalbuminuria in non-diabetic elderly subjects and their relation to blood pressure. Clin Sci Colch, 1995,88 (2):185.
  • 6[6]Zimmet PZ,McCarty DJ,de-Courten MP. The global epidemiology of non-insulin-dependent diabetes mellitus and the metabolic syndrome. J Diabetes Complications, 1997,11(2) :60.
  • 7[7]Wasada T,Katsumori K,Saeki A,et al. Urinary albumin excretion rate is related to insulin resistance in normotensive subjects with impaired glucose tolerance. Diabetes Res Clin Pract, 1997,34(3): 157.
  • 8[8]Bianchi S,Bigazzi R,Quinones GA,et al. Insulin resistance in microalbuminuric hypertension. Sites and mechanisms. Hypertension, 1995,26 (5): 789.
  • 9[9]Redon J ,Miralles A,Pascual JM,et al. Hyperinsulinemia as a determinant of microalbuminuria in essential hypertension. J Hypertens, 1997,15 (1): 79.
  • 10[10]Bianchi S,Bigazzi R ,Quinones GA,et al. Insulin resistance in microalbuminuric hypertension. Sites and mechanisms. Hypertension, 1995,26 (5): 789.

同被引文献12

  • 1Hillege HL,Jamsen WM, Bak AA, et al. Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity[ J] .J Intern Med,2001 Jun;249(6) :519.
  • 2Parvanova M, Trevisan R, Iliev IP, et al. Insulin Resistance and Microalbuminuria: A Cross-Sectional, Case-Control Study of 158 Patients With Type 2 Diabetes and Different Degrees of Urinary Albumin Excretion[ J]. Diabetes, 2006,55(5) : 1456.
  • 3The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus[ J]. Diabetes Care, 2002,25: S5.
  • 4Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man [ J ]. Diabetologia, 1985,28 (7) :412.
  • 5KRUAZYNSKA Y T,YU J G,OLEFSKY J M,et al.Effects troglitazone on blood concentrations of plasmiongen activator inhibitor 1 in patients with type 2 diabites and in lean and obese normal subjects[J].Diabetes,2000,49:633.
  • 6VAGUE J,VAGUE P,ALESSI MC.Relationship between plasma insulin triglyceride,body mass index,and plasminogen activator[J].Diabetes Metab,1987,13(3):331.
  • 7GRUDEN G,CAVALLO P P,BAZZAN M,et al.PAI-1 and factor VII activity are higher in IDDM patients with microalbuminuria[J].Diabetes,1994,43(3):426.
  • 8HIRANO T,KASHIWAZAKI K,MORITOMO Y,et al.Albuminuria is directly associated with increased plasma PAI-1 and factor Ⅷ levels in NIDDM patients[J].Diabetes Res Clin Pract,1997,36(1):11.
  • 9路影,蓝红林,马维红.老年2型糖尿病患者微量白蛋白尿与胰岛素抵抗的关系[J].中华老年医学杂志,1999,18(2):77-79. 被引量:27
  • 10李秀钧,钱荣立.胰岛素抵抗及其临床意义[J].中国糖尿病杂志,1999,7(3):163-167. 被引量:116

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部